KAPPA-TYPE
MOLECULAR TARGETKappa-type opioid receptor (human)
KAPPA-TYPE (Kappa-type opioid receptor (human)) is targeted by 60 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KAPPA-TYPE
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 60 compounds. Use the BiohacksAI search to explore all KAPPA-TYPE modulators.
About KAPPA-TYPE as a Drug Target
KAPPA-TYPE (Kappa-type opioid receptor (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 60 compounds with documented KAPPA-TYPE interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KAPPA-TYPE inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.